TipRanks
Go Ultimate55% OFF
PC:ENVED

Enveda: Valuation, Funding & Investors

Enveda is a biotechnology company that leverages AI-powered tools to accelerate the development of new medicines by learning from natural chemistry. As a clinical-stage firm, Enveda focuses on harnessing the potential of life’s chemistry to create innovative therapeutic solutions.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
$1B
Total Amount Raised
$300M
Total Funding Rounds
2
Latest Funding Amount
$150M
Latest Funding Round
Investment
Post-Money Valuation
$1B

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 04, 2025Investment$150.00M$1.00B
Sep 04, 2025Series D$150.00M―

Investors

Investor NameFunding Round
KinnevikSeries D
Premji InvestSeries D
Lux CapitalSeries D
Lingotto Investment ManagementSeries D
Baillie GiffordSeries D
IA VenturesSeries D
Peakline PartnersSeries D
FPVSeries D

Similar Companies

A snapshot of private companies similar to Enveda, helping you discover and navigate related company profiles.

Related News and Analysis